Literature DB >> 6929749

Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome.

E K Sleator.   

Abstract

Two pediatricians failed to recognize Gilles de la Tourette syndrome in a child. The symptoms were exacerbated after the child took both pemoline and methylphenidate. All medications commonly used to treat hyperactivity may cause such exacerbation. Gilles de la Tourette syndrome is frequently associated with symptoms characteristic of hyperactivity and often goes unrecognized for long periods of time. The symptoms of the syndrome and the evidence that they are exacerbated by medication used to hyperactivity are briefly reviewed. Physicians should be aware of the possibility of Gilles de la Tourette syndrome in any hyperactive patient who manifests or has a history of a tic.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6929749     DOI: 10.1177/000992288001900704

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  5 in total

Review 1.  Gilles de la Tourette syndrome: a review.

Authors:  M Lawden
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Gilles de la Tourette's syndrome in monozygotic twins.

Authors:  J Waserman; S Lal; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

4.  The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys.

Authors:  J S Rodriguez; S M Morris; C E Hotchkiss; D R Doerge; R R Allen; D R Mattison; M G Paule
Journal:  Neurotoxicol Teratol       Date:  2009-09-06       Impact factor: 3.763

5.  A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems.

Authors:  D E Comings; B G Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.